Topics

Regeneron’s Cholesterol Drug Aces Phase III, Teeing Up US FIling

07:38 EDT 15 Aug 2019 | SCRIP

The trial linked ANGPTL3 antibody evinacumab to a steep decline in LDL cholesterol in patients with homozygous familial hypercholesterolemia, setting...

      

Related Stories

 

Original Article: Regeneron’s Cholesterol Drug Aces Phase III, Teeing Up US FIling

NEXT ARTICLE

More From BioPortfolio on "Regeneron’s Cholesterol Drug Aces Phase III, Teeing Up US FIling"

Quick Search

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...